David Dolphin

Dr. David Dolphin is a distinguished professor in the Department of Chemistry at the University of British Columbia (UBC). He is renowned for his pioneering research in the synthesis and application of porphyrins, chlorins, and related macrocyclic compounds. His work has significantly advanced the understanding of these molecules in various fields, including photodynamic therapy, materials science, and supramolecular chemistry. Dr. Dolphin has made substantial contributions to the development of photosensitizers for cancer treatment and has explored the use of porphyrins in drug delivery systems. His research also extends to the study of metal complexes and their interactions with biological systems. With a career spanning several decades, Dr. Dolphin has published extensively in leading scientific journals and has mentored numerous students and researchers. His work continues to influence both academic and industrial research in the field of chemical biology and materials science.

David Dolphin's research focuses on porphyrins and their derivatives, with an emphasis on their biochemical and medical applications. His work explores the structure, reactivity, and biological significance of porphyrin-based compounds, including their roles in photodynamic therapy and enzymatic processes. Dolphin has investigated the properties of porphyrin radicals, such as π-cation radicals, and their relevance to catalytic mechanisms and biological systems. His research also includes the synthesis and characterization of novel porphyrin analogs, such as sapphyrins and polyhaloporphyrins, which exhibit unique reactivity and potential therapeutic applications. Additionally, he has contributed to the study of glutathione and its biochemical and medical implications.